BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18312620)

  • 1. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase in celiac disease: role of autoantibodies.
    Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
    Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
    Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
    Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
    Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
    Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
    Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
    Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
    J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
    Nurmi R; Korponay-Szabó I; Laurila K; Huhtala H; Niemelä O; Mustonen J; Mäkelä S; Kaukinen K; Lindfors K
    Nutrients; 2021 May; 13(5):. PubMed ID: 34064541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
    Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
    Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
    Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.